Key Facts
• On August 5, 2025, U.S. Health Secretary Kennedy announced halting mRNA vaccine support.
• The decision impacts 22 projects funded by BARDA, totaling $500 million.
• Kennedy emphasized reallocating funds to safer, broader vaccines effective against virus mutations.
• Some late-stage research will continue to preserve taxpayer investments.
• Virologist Rick Bright criticized the move, citing risks to future biological threat defenses.
• mRNA vaccines were first used during the COVID-19 pandemic and earned a Nobel Prize in 2023.
• In June 2025, Kennedy dismissed all CDC advisory committee members, appointing vaccine critics.
Summary
U.S. Health Secretary Kennedy announced the cessation of government support for mRNA vaccine development, affecting 22 BARDA-funded projects worth $500 million. Kennedy stated the funds would be redirected to safer, broader vaccines capable of addressing virus mutations. While some late-stage research will continue, critics, including virologist Rick Bright, warned the decision could weaken defenses against future biological threats. mRNA vaccines, first implemented during the COVID-19 pandemic, were pivotal in earning a Nobel Prize in 2023. Kennedy, a former anti-vaccine activist, previously dismissed all CDC advisory committee members in June 2025, replacing them with vaccine skeptics.
